Summit Therapeutics' lung cancer treatment outperformed Merck’s Keytruda. The CEO behind it is a living challenge to the assumptions of many in biotech. trib.al/EKStSJN

Apple Watch's new sleep apnea feature will use onboard sensors to detect the dangerous disorder where people have interrupted breathing. trib.al/AIrny8q

Opinion: The upcoming presidential debate is the perfect opportunity for both candidates to inform voters how they will address the most pressing public health issue of our time. trib.al/UiJQ7M4

This week's edition of Health Care Inc. looks at the major hospitals that helped take R1 RCM private and the rise of complex physician visits. trib.al/edV6Ti6

One of biopharma's marvels this decade has been the enormous success of GLP-1 drugs. In a new First Opinion, Jeffrey Flier shares how Pfizer passed on his work on this class of drugs in the '90s. trib.al/j0gRwcV

Opinion: Breakthrough therapies have given Duchenne muscular dystrophy families hope. But Duchenne is still far from being solved. trib.al/rW9S1k5

Candid Therapeutics launches with $370 million to develop autoimmune therapies. trib.al/v9AJZj5

Paralympians struggle to even describe the neuropathic pain they experience. trib.al/BWOW0f3

House passes bill that targets China biotechs statnews.com/2024/09/09/hou…

The BIOSECURE Act would prohibit the U.S. government from contracting with, or providing grants to, U.S. companies doing business with five Chinese companies. trib.al/5cxBZS6

Lyme disease and long Covid share many qualities, including being misunderstood. Now as efforts to demystify long Covid intensify, so does interest in studying neglected conditions like Lyme. trib.al/vJFpW1F

At the center of Summit Therapeutics' victory in non-small cell lung cancer is one of the industry’s most iconoclastic figures. trib.al/YttchM0

Private equity firms are leading the buyout of one major provider of billing and administrative services for hospitals and physician groups. Its hospital customers were influential in steering the company that way. trib.al/RHbDbfd

A race-free way to measure kidney function may help more Black patients get transplants, but social and health problems dwarf the impact of changing one algorithm at a safety net… trib.al/Ath0I5B

Study participants’ vision improved and lasted for 12 months, with no serious side effects. trib.al/1Y4WgNd

In this video, we explain how The Hatch-Waxman Act works to extend brand-name drug patent protection and also facilitate generic drug market entry, but also how it is limited in… trib.al/ZLXZqYC

Two former Verily executives say that they are starting a new initiative, Highlander Health, to push forward an effort decades in the making. trib.al/HHnmt7j

Roivant executives believe that mosliciguat, administered once per day using a dry powder inhaler, will help fill "an unmet medical need." trib.al/s867juf

Viridian Therapeutics said Tuesday that an experimental treatment improved the signs and symptoms of thyroid eye disease — results that achieved the primary goals of a Phase 3 clinical trial… trib.al/PeXXz3M

Pharma is still struggling to widen access to medicines — and reach patients — in low- and middle-income countries, a new analysis finds. trib.al/nznXazC